Skip to main content Skip to section navigation Skip to footer
Careers
Codexis, Inc. Corporate Page
  • About Us
    • Overview
    • Culture
    • Our People
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Sustainability
  • Services
    • Overview
    • Pharmaceutical Biocatalysis
    • RNA Manufacturing
  • Technology
    • CodeEvolver® Platform
    • ECO Synthesis™ Technology
  • Technical Content
  • Newsroom
    • Overview
    • In The News
    • Media Assets
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • chevron_leftCareers

Access our TIDES USA 2025 Investor Recap Call

View Replay

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • TIDES US
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • At-a-Glance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • TIDES US
Oct 1, 2018 7:00 am EDT
Codexis Appoints Claus Ladefoged to Global Enzyme Business Development Role
Read More
Aug 29, 2018 7:00 am EDT
Codexis to Present at Three Investment Conferences in September
Read More
Aug 8, 2018 4:05 pm EDT
Codexis Reports Second Quarter 2018 Financial Results
Read More
Aug 1, 2018 7:00 am EDT
Codexis to Hold Second Quarter 2018 Conference Call on August 8
Read More
Jul 11, 2018 7:00 am EDT
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development
Read More
Jul 9, 2018 8:00 am EDT
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
Read More
May 29, 2018 7:00 am EDT
Codexis to Present at Three Upcoming Investment Conferences
Read More
May 10, 2018 4:05 pm EDT
Codexis Reports First Quarter 2018 Financial Results
Read More
May 3, 2018 7:00 am EDT
Codexis to Hold First Quarter 2018 Conference Call on May 10
Read More
Apr 23, 2018 6:00 am EDT
Porton Pharma Solutions and Codexis Launch Global Partnership
Read More
  • Previous Pagechevron_left
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagechevron_right
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed

Headquarters

200 Penobscot Drive
Redwood City, California
94063

Contact Us

©2025 Codexis, Inc. All Rights Reserved.
  • Sitemap
  • Terms of Sale
  • Trademarks
  • Terms of Use
  • Privacy
  • Accessibility Statement
  • Disclaimer
  • Patents
  • Events
  • Careers